WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009061681) ANTAGONISTS OF PGD2 RECEPTORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/061681    International Application No.:    PCT/US2008/082082
Publication Date: 14.05.2009 International Filing Date: 31.10.2008
IPC:
C07D 257/08 (2006.01)
Applicants: AMIRA PHARMACEUTICALS, INC [US/US]; 9535 Waples Street, Suite 100, San Diego, California 92121 (US) (For All Designated States Except US).
STEARNS, Brian Andrew [US/US]; (US) (For US Only).
HUTCHINSON, John Howard [US/US]; (US) (For US Only)
Inventors: STEARNS, Brian Andrew; (US).
HUTCHINSON, John Howard; (US)
Agent: WILSON SONSINI GOODRICH & ROSATI; 650 Page Mill Road, Palo Alto, California 94304-1050 (US)
Priority Data:
60/985,913 06.11.2007 US
Title (EN) ANTAGONISTS OF PGD2 RECEPTORS
(FR) ANTAGONISTES DE RÉCEPTEURS PGD2
Abstract: front page image
(EN)Described herein are compounds and pharmaceutical compositions containing such compounds that modulate the PGD2 activated chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2). Also described herein are methods of using such CRTH2 modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2 mediated conditions or diseases.
(FR)L'invention concerne des composés et des compositions pharmaceutiques contenant de tels composés qui modulent l'activité de la molécule homologue de récepteur à fonction chimioattractive activée PGD2 exprimée sur des cellules TH2 (CRTH2). Des procédés d'utilisation de tels modulateurs de CRTH2, seuls et en combinaison avec d'autres composés, pour le traitement de maladies respiratoires, cardio-vasculaires, et autres maladies ou états dépendants de PGD2, ou provoqués par PGD2 sont également décrits.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)